YQYawei Qiu

Yawei Qiu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yawei Qiu has a total of 39 co-authors. Here are the top co-authors by number of shared publications:

  • Jinfeng Miao

    College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China

    3 shared publications
  • Dawei Guo

    Engineering Center of Innovative Veterinary Drugs, Center for Veterinary Drug Research and Evaluation, MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, 1 Weigang, Nanjing 210095, China

    2 shared publications
  • Hui Ji

    Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, 1 Weigang, Nanjing 210095, China

    2 shared publications
  • Jinqiu Zhang

    College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, 210095, China; Institute of Veterinary Immunology & Engineering, Jiangsu Academy of Agricultural Sciences, Nanjing, 210014, China; Engineering Research Center for the Prevention and Control of Animal Original Zoonosis & College of Life Science, Longyan University, Longyan, 364012, China; College of Veterinary Medicine, Shanxi Agricultural University, Jinzhong, 030801, China

    2 shared publications
  • Lin Peng

    Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, 1 Weigang, Nanjing 210095, China

    2 shared publications
  • Xiuge Gao

    Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, 1 Weigang, Nanjing 210095, China

    2 shared publications

Latest Publications

  • Open Access

    Gut Barrier Dysfunction and Microbiota Variations in Cryptosporidiosis: A Comprehensive Review

    by Munwar Ali, Chang Xu, Mingyue Wang, Qazal Hina, Yaru Ji, Subiha Anwar, Sijia Lu, Qing He, Yawei Qiu, Kun Li

    Cryptosporidiosis is a zoonotic protozoan parasite-born disease, equally significant in both animals and humans, especially affecting immunocompromised individuals (e.g., AIDS patients) and neonates. The prime concerns of this review article are to demonstrate the disruption of the intestinal barrier and variations in the gut microbiome during cryptosporidiosis, and to explore host gut–parasite interactions that can lead to the development of novel therapeutics. The review concluded that the enteric barrier is particularly maintained by tight junction proteins (e.g., occludin, claudin, and ZO-1, etc.) and mucosal immunity, both of which are severely compromised during Cryptosporidium spp. infections, resulting in increased intestinal barrier permeability, inflammatory responses, diarrhea, and ultimately death in severe cases. Cryptosporidium-induced dysbiosis is characterized by reduced microbial diversity and richness, a shift from commensal to pathogenic bacteria, as evidenced by increased pro-inflammatory taxa like Proteobacteria, and reduced proportions of beneficial SCFAs producing bacteria, e.g., Firmicutes. Recent investigations have highlighted the interrelations between gut microbiota and epithelial barrier integrity, especially during cryptosporidiosis, demonstrating the modulations regarding tight junctions (TJs), immune reactions, and SCFA production, all of which are main players in alleviating this protozoal parasitic infection. This review comprehensively describes the fine details underlying these impairments, including autophagy-mediated TJs’ degradation, inflammasome activation, and gut microbiome-driven alterations in metabolic pathways, providing the latest relevant, and well-organized piece of knowledge regarding intestinal barrier alterations and microbial shifts during cryptosporidiosis. This work emphasizes the future need for longitudinal studies and advanced sequencing techniques to understand host gut microbiota–parasite interactions, aiming to formulate innovative strategies to mitigate cryptosporidiosis.


  • Open Access

    Seasonal and Regional Dynamics of Mastitis Pathogens: Insights From a 3‐Year Study in China

    by Yawei Qiu, Shaodong Fu, Naiyan Sun, Bo Yang, Shiyuan Feng, Jinqiu Zhang, Dancheng Yang, Jinfeng Miao

    Mastitis is one of the biggest problems and an economic burden facing the dairy industry with a strong negative impact on animal welfare, productivity, and food safety. This study conducted a systematic investigation and analysis of the epidemiological characteristics of mastitis in selected regions of China (significant region for raw milk production). By collecting an extensive number of milk samples from clinical mastitis cases and utilizing methodologies such as bacterial isolation, genomic DNA extraction, and pathogen identification, the research elucidated the distribution patterns and trends of pathogenic bacteria responsible for mastitis across various regions and seasons. A total of 7177 milk samples were analyzed, identifying pathogenic bacteria in 3720 samples, which corresponds to a detection rate of 51.83%. Sixteen species of pathogenic bacteria were identified, with Klebsiella , coagulase‐negative staphylococci (CoNS), and Escherichia coli ( E. coli ) being the predominant pathogens, representing 21.33%, 20.63%, and 18.72%, respectively. The study revealed significant seasonal and regional variations in the prevalence of pathogenic bacteria associated with mastitis. Detection rates of these bacteria were significantly higher in samples collected from May to September compared to other months, with September showing the highest detection rate at 85.94%. Furthermore, the southern region of China demonstrated the highest detection rate of pathogenic bacteria, with a prevalence of 94.98%. This study explored the pathogenicity and antimicrobial resistance profiles of the predominant bacterial strains, and proposed targeted prevention and control strategies based on these insights. The overarching aim is to provide a scientific basis for the effective management of mastitis, thereby alleviating the economic impact on the dairy farming industry.


  • Classifying and Understanding of Dairy Cattle Health Using Wearable Inertial Sensors With Random Forest and Explainable Artificial Intelligence

    by Zhonghao Shi, Fangyuan Chang, Yuanzheng Jia, Jun Li, Yawei Qiu, Jinfeng Miao, Wei Jiang, Xiaojun Guo, Xiangan Han, Wei Tang

    Recent developments in the field of machine learning andwearable sensor technology have led to a renewed interest in the efficient monitoring of cattle health conditions. Wearable inertial sensors are particularly suited for a noninvasive solution to assess cattle health by continuously providing their daily behavior information. However, current classification methods have limitations in terms of the lack of interpretability analysis of the resulting models for the combined behaviors. In this study, a data-driven assessment approach was proposed to classify and understand cattle health through behavior recognition and health classification algorithms. Data were collected through wearable sensors attached to the cattle's collar and leg, providing acceleration, angular velocity, and Euler angles. Random forest was used to implement behavior recognition and health classification of dairy cattle, which was incorporated with explainable artificial intelligence (XAI) for result interpretation. The behavior recognition model achieves high accuracy in distinguishing between behaviors. The health classification model exhibits a strong discriminative ability, and the receiver operating characteristic curve confirms its effectiveness in identifying cattle health status using behavior data. The results showcase the crucial role of XAI analysis in establishing a correlational description between the combined behavioral characteristics of cows and their health classification. This work not only enhances the credibility of the development model but also offers valuable guidance for the predictions of cattle health by motion and feeding behaviors.


  • Immune response variations and intestinal flora changes in mastitis induced by three Streptococcus uberis strains

    by Shaodong Fu, Yuanyuan Zhou, Yawei Qiu, Wei Chen, Jinqiu Zhang, Jinfeng Miao

    Streptococcus uberis is a common cause of mastitis. The pathogenicity among different strains of S. uberis and the resultant host immune responses remain to be elucidated. Herein, we document immune responses among three strains of S. uberis, and preliminary explore whether and how intestinal immunity plays a role in host anti‐infection processes. Mice have been proved to be effective experimental animals for bovine mastitis, so utilizing a mouse intramammary infection model, we assay immune responses and gut flora changes of three S. uberis strains by histopathologic examination, RT‐PCR, Western blot, and 16s ribosomal DNA sequencing. We find that the immune responses among the three sequence‐type (ST) S. uberis strains may be linked to the hasA/B and lbp virulence genes, and the beta diversity of the intestine may be independent of the ST of S. uberis. Twenty phyla and 30 genera of intestinal flora were identified, with Verrucomicrobia and Akkermansia being the most prominent phylum and genus, respectively. These bacteria have strong anti‐inflammatory and protective effects against S. uberis challenge. These data provide a foundation for further studies to elucidate gut flora function and exploration of therapeutic targets for mastitis.


  • Open Access

    Development and Validation of an Ultra-Performance Liquid Chromatography–Tandem Mass Spectrometry Method to Determine Maduramicin in Crayfish (Procambarus clarkii) and Evaluate Food Safety

    by Xiuge Gao, Pei Teng, Lin Peng, Hui Ji, Yawei Qiu, Xiaoxiao Liu, Dawei Guo, Shanxiang Jiang

    Maduramicin (MAD) is widely introduced into aquatic environments and results in the contamination of fish products. Worryingly, the consumption of MAD-contaminated crayfish (Procambarus clarkii) may induce symptoms of Haff disease. In this study, to monitor this potential contamination and to understand the residue and elimination characteristics of MAD in edible tissues of crayfish, a sensitive and efficient ultra-performance liquid chromatography–tandem mass spectrometry method was developed, validated, and applied. After extraction with acetonitrile and purification by solid-phase extraction column, multiple-reaction monitoring mass spectrometry with positive ionization mode was used to determine MAD’s residues. The limits of detection and of quantification were 6 μg·kg−1 and 20 μg·kg−1, respectively. The fortified recoveries ranged from 74.2% to 110.4%, with relative standard deviation of 1.2% to 10.1%. Furthermore, MAD was completely eliminated after 3 and 5 days from abdominal muscle and hepatopancreas tissues of crayfish, respectively. The maximum residue limits (MRLs) of MAD respectively was 200 μg·kg−1 in muscle and 600 μg·kg−1 in the hepatopancreas, and its withdrawal time in both edible tissues was 25.8 °C·d. Collectively, the results of this study indicate the proposed method is an efficient tool to evaluate the public health risk associated with crayfish consumption.


  • Open Access

    Ionophore Toxin Maduramicin Produces Haff Disease-Like Rhabdomyolysis in a Mouse Model

    by Xiuge Gao, Xinhao Song, Runan Zuo, Dan Yang, Chunlei Ji, Hui Ji, Lin Peng, Yawei Qiu, Dawei Guo, Shanxiang Jiang

    Maduramicin is a toxic ionophore antibiotic that is isolated from Streptomyces, frequently occurring in an aquatic environment. To understand the potential role of maduramicin in crayfish consumption related Haff disease, a mouse model was established in this study. Two exposure routes of maduramicin in the abdominal muscle and the hepatopancreas tissue homogenates of crayfish were given intragastrically to mice in different doses for seven days. Action changes, clinical symptoms, feed consumption, body weight, blood biochemistry, and histopathology examination of mice were observed and analyzed. In the natural exposure group, relatively low concentration of maduramicin in crayfish muscle and hepatopancreas had no obvious effects on mental state, body weight, blood biochemical indexes, or histologic appearance. However, in the artificial exposure group, with increasing concentrations, maduramicin in crayfish muscle and hepatopancreas homogenates both induced mental sluggishness and weight loss of mice. Blood biochemical examination showed that 3.5 mg·kg−1 and 7 mg·kg−1 maduramicin in crayfish tissue homogenates significantly increased levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), blood urea nitrogen (BUN), lactate dehydrogenase (LDH), and creatine kinase (CK). Additionally, histopathological examination showed that multiple organs were damaged by maduramicin, including degeneration of liver cells, shedding of renal epithelial cells, and disturbance and partial lysis of myocardial and skeletal muscle filaments in the mice. In summary, maduramicin may not cause Haff disease through contamination of the aquatic environment under normal conditions. Maduramicin can be used as a potential toxin tool to establish a rhabdomyolysis disease animal model for drug development.